Genetic Technologies Limited
GNTLF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $311,963 | $15,659 | $12,409 | $21,753 |
| - Cash | $1,013 | $1,021 | $3,729 | $7,851 |
| + Debt | $500 | $875 | $382 | $533 |
| Enterprise Value | $311,450 | $15,514 | $9,062 | $14,435 |
| Revenue | $414 | $4,800 | $3,959 | $4,532 |
| % Growth | -91.4% | 21.2% | -12.7% | – |
| Gross Profit | $414 | $2,796 | -$1,981 | -$1,223 |
| % Margin | 100% | 58.3% | -50% | -27% |
| EBITDA | -$1,331 | -$5,305 | -$2,044 | -$5,941 |
| % Margin | -321.6% | -110.5% | -51.6% | -131.1% |
| Net Income | -$4,087 | -$5,598 | -$6,419 | -$6,291 |
| % Margin | -987.2% | -116.6% | -162.2% | -138.8% |
| EPS Diluted | -0.021 | -0.038 | -0.053 | -0.065 |
| % Growth | 43.6% | 29.2% | 18.4% | – |
| Operating Cash Flow | -$71 | -$5,667 | -$3,896 | -$3,479 |
| Capital Expenditures | -$7 | -$5 | -$7 | -$14 |
| Free Cash Flow | -$78 | -$5,672 | -$3,903 | -$2,487 |